Alembic Pharmaceuticals LimitedNSE: APLLTD

Press Release Dec 03 2020

· Issued by Alembic Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-dec-03-2020-3

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated December 03, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Metolazone Tablets USP 2.5 mg, 5 mg, and 10 mg.".

View Attachment

6ix hasn’t read this filing yet.

Alembic Pharmaceuticals Limited on 6ix

Earlier from Alembic Pharmaceuticals

Later from Alembic Pharmaceuticals

All Alembic Pharmaceuticals news releases